Progyny Enhances Male Fertility Offering with the Expansion of its Reproductive Urologist Network
Progyny, Inc. (Nasdaq: PGNY) announced a significant expansion of its provider network to include reproductive urologists (RUs), addressing a critical aspect of male-factor infertility. This move enhances access to quality urological care, complementing Progyny's existing network of over 650 clinics and 950 fertility specialists. Male-factor infertility represents approximately one-third of infertility cases, highlighting the importance of this expansion. The company collaborated with its reproductive endocrinology partners to ensure RUs meet high standards. CEO Pete Anevski emphasized the need for comprehensive infertility solutions, underlining the commitment to supporting all individuals seeking parenthood.
- Expansion of provider network to include reproductive urologists enhances access to care.
- Addresses male-factor infertility, which accounts for roughly one-third of infertility cases.
- Collaboration with established reproductive endocrinology partners ensures high-quality urological care.
- None.
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced the expansion of its provider network to include reproductive urologists (RU). Patients with Progyny’s comprehensive and equitable solution will now have convenient access to high-quality urological care, in addition to the existing Progyny network made up of more than 650 clinics and over 950 leading fertility specialists.
Currently, about one third of infertility cases are due to one partner being unable to create and ejaculate healthy sperm, often referred to as male-factor infertility. While Progyny has already been covering several treatments for sperm-related infertility through its reproductive endocrinology and infertility (REI) network, there are those who need further evaluation from a RU, a doctor who specializes in reproductive health for people who produce sperm. Progyny is proud to now offer coverage and access to a curated network of accredited RUs for those individuals.
“Infertility impacts millions of people and sperm related infertility accounts for a sizable portion, yet most of the conversation and responsibility falls to the female population,” said Pete Anevski, Progyny’s CEO. “At Progyny, we work to address all areas of infertility to provide the best services and treatments possible to ensure everyone’s dreams of parenthood are realized. Expanding our male fertility offering to include a RU network of best-in-class physicians is a vital step to furthering this mission.”
To expand Progyny’s provider network, the company worked closely with its well-respected REI partners to distinguish RUs that provide best-in-class urological care. Each RU has been vetted to meet Progyny’s network standards and will work collaboratively with the REIs to ensure a streamlined and cohesive patient experience.
“I am very excited to be involved in the roll-out of Progyny’s extended coverage for male-factor infertility. This is a great opportunity for patients to have expanded coverage to optimize their chances of achieving their family building goals,” said Dr. Shane Russell, a reproductive urologist in Progyny’s network. “The Progyny team has been great to work with and I look forward to a long and productive partnership with them.”
To find a reproductive urologist in Progyny’s network, please visit: https://providersearch.progyny.com/.
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.
Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
| For Further Information, Please Contact: | |
| Investors: James Hart investors@progyny.com | Media: Selena Yang media@progyny.com |
FAQ
What recent announcement did Progyny (PGNY) make regarding its provider network?
Why is the inclusion of reproductive urologists significant for Progyny (PGNY)?
How many clinics and specialists are part of Progyny's network after the expansion?
What is the purpose of Progyny's collaboration with reproductive endocrinology partners?
